NORDITROPIN 5 MG

País: Israel

Língua: inglês

Origem: Ministry of Health

Ingredientes ativos:

SOMATROPIN

Disponível em:

NOVO NORDISK LTD., ISRAEL

Código ATC:

H01AC01

Forma farmacêutica:

SOLUTION FOR INJECTION

Composição:

SOMATROPIN 3.3 MG / 1 ML

Via de administração:

S.C

Tipo de prescrição:

Required

Fabricado por:

NOVO NORDISK A/S, DENMARK

Grupo terapêutico:

SOMATROPIN

Área terapêutica:

SOMATROPIN

Indicações terapêuticas:

Children: Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome. Short stature in children with renal insufficiency. Growth disturbance (current height SDS < - 2.5 and parental adjusted height SDS < - 1) in short children born small for gestational age (SGA) with a birth weight and/or length below - 2 SD who failed to show catch-up growth (HV SDS < during the last year) by 4 years of age or later.Children with short stature associated with Noonan syndrome.Adults: Treatment of adults with Hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of G.H. deficiency. תוספת התוויה: 5/6/2019Indication:Children: Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome.Short stature in children with renal insufficiency.Growth disturbance (current height SDS < -2.5 and parental adjusted height SDS < -1) in short childre

Data de autorização:

2020-05-31